Page last updated: 2024-09-04

resiquimod and cp 105696

resiquimod has been researched along with cp 105696 in 1 studies

Compound Research Comparison

Studies
(resiquimod)
Trials
(resiquimod)
Recent Studies (post-2010)
(resiquimod)
Studies
(cp 105696)
Trials
(cp 105696)
Recent Studies (post-2010) (cp 105696)
465143183316

Protein Interaction Comparison

ProteinTaxonomyresiquimod (IC50)cp 105696 (IC50)
Leukotriene B4 receptor 1Homo sapiens (human)0.1131
Leukotriene B4 receptor 2Homo sapiens (human)0.2192
Cysteinyl leukotriene receptor 2Homo sapiens (human)0.0084
Cysteinyl leukotriene receptor 1Homo sapiens (human)0.0084

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Borgeat, P; Flamand, L; Gravel, A; Lefebvre, JS; Lévesque, T; Paré, G; Picard, S1

Other Studies

1 other study(ies) available for resiquimod and cp 105696

ArticleYear
Extra domain A of fibronectin primes leukotriene biosynthesis and stimulates neutrophil migration through activation of Toll-like receptor 4.
    Arthritis and rheumatism, 2011, Volume: 63, Issue:6

    Topics: Animals; Anti-Inflammatory Agents; Benzopyrans; Carboxylic Acids; Cytokines; Female; Fibronectins; Humans; Imidazoles; Leukotriene B4; Leukotrienes; Lipopeptides; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Monocytes; Neutrophils; Protein Isoforms; Pyrrolidines; Recombinant Proteins; Sulfonamides; Toll-Like Receptor 4; Transendothelial and Transepithelial Migration

2011